Tumeric Capital, the Singapore-based private equity firm led by former L Catterton Asia head Ravi Thakran, is said to be exploring listing a special purpose acquisition company (SPAC) in Singapore, according to a Bloomberg report.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
